Skip to main content
SpringerLink
Log in

Apoptosis Detected with Monoclonal Antibody to Single-stranded DNA is a Predictor of Recurrence in Intracranial Meningiomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Precise quantitation of apoptotic cells in meningiomas is necessary to determine the role of apoptosis in tumor growth and recurrence. In this study, we investigated the incidence of baseline apoptosis in relation to p53 and bcl-2 protein expression, proliferation status as expressed by Ki-67, PCNA and mitotic counts, standard clinicopathological parameters and patients' outcome, in a series of 59 patients with primary intracranial benign and atypical meningiomas. Seven tumors recurred (11.9%) following complete surgical resection, within a follow-up period ranging from 21 to 108 months. Apoptotic fractions were quantified immunohistochemically by means of a novel monoclonal antibody recognizing exposed single-stranded (ss) regions in the DNA of apoptotic cells during heating. Tissues consisted of archival formalin-fixed paraffin-embedded meningioma specimens. The apoptotic index (AI) ranged from 0% to 2.90% (mean: 0.50%), increased with proliferative activity (p = 0.014), had lower values in transitional meningiomas (p = 0.001) and was unrelated to grade and p53 expression. Increased AI predominated among bcl-2 negative tumors (p = 0.041) and tended to be accompanied by a shortened recurrence-free survival, in univariate (p = 0.0407) as well as in multivariate analysis (p = 0.0405). These results implicate apoptotic rate in meningioma growth and recurrence and denote that assessment of apoptotic potential by means of anti-ssDNA monoclonal antibody provides valid prognostic information irrespective of other parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Christensen E, Laursen H, Klinken L: Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 61: 130–134, 1983

    Google Scholar 

  2. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojeman RG, Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18–24, 1985

    Google Scholar 

  3. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF: Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23: 349–353, 1993

    Google Scholar 

  4. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: Malignancy in meningiomas: a clinicopathological study of 116 patients, with grading implications. Cancer 85: 2046–2056, 1999

    Google Scholar 

  5. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ: Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and Genetics of Tumors of the Nervous System. 2nd edn. International Agency for Research, Lyon, 2000, pp 176–184

    Google Scholar 

  6. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097–1098, 1991

    Google Scholar 

  7. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC: The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate. Cancer 75: 522–529, 1995

    Google Scholar 

  8. Lipponen PK, Aaltomaa S: Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 173: 333–339, 1994

    Google Scholar 

  9. Lipponen PK, Aaltomaa S, Kosma V-M, Syrjanen K: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A: 2068–2073, 1994

    Google Scholar 

  10. Tormanen U, Eerola AK, Rainio P, Vahakangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Paako P: Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55: 5595–5602, 1995

    Google Scholar 

  11. Korkolopoulou P, Konstantinidou A-E, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P: Detection of apoptotic cells in archival tissue from diffuse astrocytomas using a monoclonal antibody to single-stranded DNA. J Pathol 193: 377–382, 2001

    Google Scholar 

  12. Migheli A, Cavalla P, Marino S, Schiffer D: A study of apoptosis in normal and pathological nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53: 606–616, 1994

    Google Scholar 

  13. Patsouris E, Davaki P, Kapranos N, Davaris P, Papageorgiou K: A study of apoptosis in brain tumors by in situ end-labeling method. Clin Neuropathol 15: 337–341, 1996

    Google Scholar 

  14. Yew DT, Wang HH, Zheng DR: Apoptosis in astrocytomas with different grades of malignancy. Acta Neurochir (Wien) 140: 341–347, 1998

    Google Scholar 

  15. Maier H, Wanschitz J, Sedivy R, Rossler K, Ofner D, Budka H: Proliferation and DNA fragmentation in meningioma sybtypes. Neuropathol Appl Neurobiol 23: 496–506, 1997

    Google Scholar 

  16. Ng H-K, Chen L: Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labeling and immunohistochemical study. Histopathology 33: 64–70, 1998

    Google Scholar 

  17. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L: Monoclonal antibody to single-stranded DNA is a specific and cellular marker of apoptosis. Exp Cell Res 226: 387–397, 1996

    Google Scholar 

  18. Konstantinidou AE, Patsouris E, Kavantzas N, Pavlopoulos PM, Bouropoulou V, Davaris P: Computerized determination of proliferating cell nuclear antigen expression in meningiomas; comparison with nonautomated method. Gen Diagn Pathol 142: 311–316, 1997

    Google Scholar 

  19. Drachenberg C, Ioffe O, Castellani R, Papadimitriou J: Nuclear bcl-2 staining in tumors. Am J Clin Pathol (letter) 108: 479, 1997

  20. Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley-Whyte ET: Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 53: 247–255, 1994

    Google Scholar 

  21. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J: Meningiomas: proliferating potential and clinicopathological features. Neurosurgery 37: 1049–1055, 1995

    Google Scholar 

  22. Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P: Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186: 325–330, 1998

    Google Scholar 

  23. Columbano A: Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58: 181–190, 1995

    Google Scholar 

  24. Earnshaw WC: Nuclear changes in apoptosis. Curr Opin Cell Biol 7: 337-343, 1995

    Google Scholar 

  25. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L: Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA. Relation to bcl-2 expression, hormone receptors and lymph node metastases. Clin Cancer Res 3: 465–471, 1997

    Google Scholar 

  26. Nakasu S, Nakajima M, Nakazawa T, Nakasu Y, Handa J: p53 accumulation and apoptosis in embolized meningiomas. Acta Neuropathol 93: 599–605, 1997

    Google Scholar 

  27. Iwaki T, Miyazono M, Hitotsumatsu T, Tateishi J: An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell-dying processes. Am J Pathol 145: 776–781, 1994

    Google Scholar 

  28. Korkolopoulou P, Konstantinidou A-E, Christodoulou P, Patsouris E, Thomas-Tsagli E, Kapralos P, Davaris P: Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA. Relation to cell cycle regulators and survival. Urology 56: 516–520, 2000

    Google Scholar 

  29. Bell DA, Morrison B: The spontaneous apoptotic cell death of normal human lymphocytes in vitro. The release of, and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol 60: 13–26, 1991

    Google Scholar 

  30. Ellison DW, Lunec J, Gallacher PJ, Steart PV, Jaros E, Gatter KC: Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21: 136–142, 1995

    Google Scholar 

  31. Frankfurt OS, Seckinger D, Sugarbaker EV: Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic response. Int J Cancer 59: 217–224, 1994

    Google Scholar 

  32. von Deimling A, Larson J, Wellenreuther R, Stangl AP, van Velthoven V, Warnick R, Tew J Jr, Balko G, Menon AG: Clonal origin of recurrent meningiomas. Brain Pathol 9: 645–650, 1999.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, National and Kapodistrian University of Athens, KAT General Hospital, Athens, Greece

    Anastasia Konstantinidou, Penelope Korkolopoulou, Efstratios Patsouris, Stavroula Hranioti, Xenophon Kotsiakis & Panagiotis Davaris

  2. Department of Pathology, KAT General Hospital, Athens, Greece

    Helen Mahera

Authors
  1. Anastasia Konstantinidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Penelope Korkolopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Efstratios Patsouris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Helen Mahera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stavroula Hranioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xenophon Kotsiakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Panagiotis Davaris
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konstantinidou, A., Korkolopoulou, P., Patsouris, E. et al. Apoptosis Detected with Monoclonal Antibody to Single-stranded DNA is a Predictor of Recurrence in Intracranial Meningiomas. J Neurooncol 55, 1–9 (2001). https://doi.org/10.1023/A:1012941202510

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012941202510

Search

Navigation